Intra Cellular Therapies | Capitale Di Prestito



Loan Capital Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 285.82M 2024-12
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Cytokinetics USD 645.6M 1.1M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Intra Cellular Therapies USD 0 0 2024-12
J&J USD 30.65B 638M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Prothena USD 0 0 2024-12
RedHill Biopharma USD 190K 0 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 0 0 2024-12



Intra Cellular Therapies Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.